Pharmacokinetics of drugs in mutant Nagase analbuminemic rats and responses to select diuretics
- PMID: 24151919
- DOI: 10.1111/jphp.12158
Pharmacokinetics of drugs in mutant Nagase analbuminemic rats and responses to select diuretics
Abstract
Objectives: To report (1) the pharmacokinetics of drugs that are mainly metabolized via hepatic cytochrome P450s (CYPs) or mainly excreted via the urine and bile, (2) the mechanism for the urinary excretion of drugs (such as glomerular filtration or renal active secretion or re-absorption), and (3) the diuretic effect of some loop diuretics in mutant Nagase analbuminaemic rats (NARs), an animal model for human familial analbuminaemia based on the pharmacokinetics of drugs reported in the literatures.
Key findings: In NARs, the changes in the time-averaged non-renal clearances (CL(NR)s) of drugs that are mainly metabolized via CYPs were explained in terms of changes in the hepatic intrinsic clearance (mainly because of changes in CYPs), free (unbound) fractions of drugs in the plasma (fp) and hepatic blood-flow rate (QH) depending on the hepatic excretion ratios of drugs.
Summary: The CL(NR) changes of drugs mainly metabolized via hepatic CYPs can be sufficiently explained by the three earlier mentioned factors. The plasma albumin (furosemide) or globulin (azosemide, bumetanide and torasemide) binding affects their diuretic effects.
Keywords: Nagase analbuminemic rats; hepatic cytochrome P450s; nephrotic syndrome; pharmacokinetics.
© 2013 Royal Pharmaceutical Society.
Similar articles
-
Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.Biopharm Drug Dispos. 2003 Jan;24(1):27-35. doi: 10.1002/bdd.333. Biopharm Drug Dispos. 2003. PMID: 12516076
-
Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects.Biopharm Drug Dispos. 2001 May;22(4):147-56. doi: 10.1002/bdd.267. Biopharm Drug Dispos. 2001. PMID: 11745917
-
Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats.Drug Metab Dispos. 2003 Feb;31(2):194-201. doi: 10.1124/dmd.31.2.194. Drug Metab Dispos. 2003. PMID: 12527700
-
Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin.Biopharm Drug Dispos. 2015 Jan;36(1):1-14. doi: 10.1002/bdd.1901. Epub 2014 Aug 6. Biopharm Drug Dispos. 2015. PMID: 24861008 Review.
-
Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus.J Pharm Pharmacol. 2010 Jan;62(1):1-23. doi: 10.1211/jpp.62.01.0001. J Pharm Pharmacol. 2010. PMID: 20722995 Review.
Cited by
-
Diagnosis, Phenotype, and Molecular Genetics of Congenital Analbuminemia.Front Genet. 2019 Apr 17;10:336. doi: 10.3389/fgene.2019.00336. eCollection 2019. Front Genet. 2019. PMID: 31057599 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical